Key result
Administering dexmedetomidine at 1 μg·kg⁻¹·h⁻¹ for 24 hours significantly reduced the incidence of atrial fibrillation after cardiac surgery compared with 0.5 μg·kg⁻¹·h⁻¹ (10.6% vs 21.8%; OR 0.394).
Why the study?
The comparative effects of various doses of dexmedetomidine on the incidence of atrial fibrillation after cardiac surgery in adults were evaluated.
Does a higher dose of dexmedetomidine (1 μg·kg⁻¹·h⁻¹) reduce the incidence of atrial fibrillation compared to a lower dose (0.5 μg·kg⁻¹·h⁻¹) in adults after elective cardiac surgery?
RCT (n=224)
randomly assigned
Does a higher dose of dexmedetomidine (1 μg·kg⁻¹·h⁻¹) reduce the incidence of atrial fibrillation compared to a lower dose (0.5 μg·kg⁻¹·h⁻¹) in adults after elective cardiac surgery?
Odds Ratio: 0.394 (95% CI 0.172–0.903)
Absolute Event Rate: 10.6% vs 21.8%
p-value: p=0.029
Administering a higher dose of dexmedetomidine (1 μg·kg⁻¹·h⁻¹) for 24 hours significantly reduces the incidence of postoperative atrial fibrillation and shortens mechanical ventilation duration compared to a 0.5 μg·kg⁻¹·h⁻¹ dose in adults undergoing elective cardiac surgery.
Dose comparison of dexmedetomidine for post-cardiac surgery AF remains inconclusive; larger trials needed before practice change.
In this study, we compared the effects of various doses of dexmedetomidine on the incidence of atrial fibrillation (AF) after cardiac surgery in adults. A total of 224 adult patients who underwent elective cardiac surgery were randomly assigned to two groups. The DEX0.5 group received a continuous infusion of dexmedetomidine at a rate of 0.5 μg·kg⁻ 1 ·h⁻ 1 , while the DEX1 group received it at a rate of 1 μg·kg⁻ 1 ·h⁻ 1 during the induction of anesthesia, which was maintained for 24 hours. The primary outcome was the incidence of AF, while the secondary outcomes included other tachyarrhythmias, bradycardia, hypotension, duration of mechanical ventilation, time spent in the cardiac care unit, and length of hospitalization. A total of 101 patients were included in the DEX0.5 group, while 104 patients were included in the DEX1 group. The incidence of AF was significantly lower in the DEX1 group compared with the DEX0.5 group (10.6% vs. 21.8%, P = 0.029). In addition, the duration of mechanical ventilation was shorter in the DEX1 group than in the DEX0.5 group (8.9 vs. 15.2 hours, P = 0.018). Logistic regression analyses were conducted to investigate the factors influencing AF. The results indicated that the dose of dexmedetomidine was the only independent predictor (odds ratio = 0.394, 95% confidence interval 0.172 to 0.903, P = 0.028). Compared with a continuous infusion of 0.5 μg·kg⁻ 1 ·h⁻ 1 , this study suggested that administering dexmedetomidine at a dose of 1 μg·kg⁻ 1 ·h⁻ 1 for 24 hours is effective in reducing the incidence of AF after cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted an RCT in Atrial fibrillation after cardiac surgery (n=224). Dexmedetomidine vs. Dexmedetomidine 0.5 μg·kg⁻¹·h⁻¹ was evaluated on Incidence of atrial fibrillation (OR 0.394, 95% CI 0.172 to 0.903, p=0.029). Administering dexmedetomidine at 1 μg·kg⁻¹·h⁻¹ for 24 hours significantly reduced the incidence of atrial fibrillation after cardiac surgery compared with 0.5 μg·kg⁻¹·h⁻¹ (10.6% vs 21.8%; OR 0.394).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: